Class II · Moderate risk
Doxazosin Tablets
CGMP Deviations
FDA Drug Recalls
381 recalls, newest first
Class II · Moderate risk
BusPIRone Hydrochloride Tablets USP
CGMP Deviations
Class II · Moderate risk
Atorvastatin Calcium Tablets
CGMP Deviations
Class II · Moderate risk
Purely Soothing MSM Nasal Spray
CGMP Deviations
Class II · Moderate risk
Delsam Pharma's ARTIFICIAL TEARS
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Class II · Moderate risk
Artificial Tears
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Class II · Moderate risk
Hand Sanitizer
CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.
Class II · Moderate risk
Hand Sanitizer
CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.
Class II · Moderate risk
Humatrix Microclysmic Gel
CGMP Deviations: initiated due to violations of CGMP manufacturing practices
Class II · Moderate risk
Techni-Care Chloroxylenold 3%
CGMP Deviations: initiated due to violations of CGMP manufacturing practices
Class II · Moderate risk
Tobramycin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Tobramycin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Timolol Maleate Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Sodium Chloride Ophthalmic Ointment
CGMP Deviations:
Class II · Moderate risk
Proparacaine Hydrochloride Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Proparacaine Hydrochloride Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCL Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Olopatadine HCl Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Ofloxacin Ophthalmic Solution
CGMP Deviations:
Class II · Moderate risk
Neomycin and Polymyxin B Sulfates
CGMP Deviations:
Class II · Moderate risk
Moxifloxacin Ophthalmic Solution
CGMP Deviations: